HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities
/in Cervical Cancer, Dendritic Cells, International Publications /von 2005-10-24 / Gynecol Oncol 2006 Mar;100(3):469-78[In vitro anti-myeloma effects induced by myeloma idiotype-protein pulsed dendritic cell vaccine]
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2005-10-01 / Zhonghua Xue Ye Xue Za Zhi 2005 Oct;26(10):593-7Natural killer-dendritic cell cross-talk in cancer immunotherapy
/in Dendritic Cells, International Publications /von 2005-10-01 / Expert Opin Biol Ther 2005 Oct;5(10):1303-15Vaccination of melanoma patients using dendritic cells loaded with an allogeneic tumor cell lysate
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2005-09-27 / Cancer Immunol Immunother 2006 Jul;55(7):819-29Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2005-09-01 / Leukemia 2005 Sep;19(9):1621-7Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2005-09-01 / J. Immunother. 2005 Sep-Oct;28(5):496-504Immunomodulatory dendritic cells require autologous serum to circumvent nonspecific immunosuppressive activity in vivo
/in Dendritic Cells, International Publications /von 2005-08-23 / Blood 2005 Dec;106(13):4225-33Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment
/in Dendritic Cells, Glioblastoma, International Publications /von 2005-08-01 / Clin. Cancer Res. 2005 Aug;11(15):5515-25Natural-killer cells and dendritic cells: „l’union fait la force“
/in Dendritic Cells, International Publications /von 2005-06-02 / Blood 2005 Oct;106(7):2252-8
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de